Patent details

EP2124547 Title: CANCER TREATMENT METHOD

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2124547
WO Application Number:
US2008054046
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP08729939.2
WO Publication Number:
WO2008101141
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
15/02/2008
Grant date:
28/03/2018
EP Publication Date:
02/12/2009
WO Publication Date:
21/08/2008
Claims Translations Received Date:
Claims Translation B1 Received Date:
13/06/2018
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
28/03/2018
EP B1 Publication Date:
28/03/2018
EP B2 Publication Date:
16/04/2025
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
14/02/2028
Lapsed By Expiration Date:
Patent Validated Date:
29/06/2018
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
28/03/2018
 
 

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, BASEL, Switzerland (CH)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
28/06/2018
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

Name:
ERICKSON-MILLER, Connie, Lynn
Address:
Collegeville, PA 19426, United States of America (US)

Priority

1

Priority Patent Number:
977216 P
Priority Date:
03/10/2007
Priority Country:
United States of America (US)

2

Priority Patent Number:
969192 P
Priority Date:
31/08/2007
Priority Country:
United States of America (US)

3

Priority Patent Number:
952289 P
Priority Date:
27/07/2007
Priority Country:
United States of America (US)

4

Priority Patent Number:
949347 P
Priority Date:
12/07/2007
Priority Country:
United States of America (US)

5

Priority Patent Number:
908205 P
Priority Date:
27/03/2007
Priority Country:
United States of America (US)

6

Priority Patent Number:
892552 P
Priority Date:
02/03/2007
Priority Country:
United States of America (US)

7

Priority Patent Number:
890236 P
Priority Date:
16/02/2007
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/655; A61K 45/06; A61P 35/00; A61P 35/02; A01N 33/16;

Publication

Bulletin

1

Bulletin Heading:
EP4
Journal edition number:
16/25
Publication date:
16/04/2025
Description:
European patents granted in amended form for the Netherlands

2

Bulletin Heading:
MED
Journal edition number:
16/25
Publication date:
16/04/2025
Description:
Other communications

3

Bulletin Heading:
VB1
Journal edition number:
06/19
Publication date:
06/02/2019
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

4

Bulletin Heading:
EP3
Journal edition number:
28/18
Publication date:
04/07/2018
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

5

Bulletin Heading:
EP2
Journal edition number:
14/18
Publication date:
28/03/2018
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202516
Publication date:
16/04/2025
Description:
Patent maintained (B2 publication)

2

Issue number:
202503
Publication date:
15/01/2025
Description:
International Patent Classification Changed

3

Issue number:
201906
Publication date:
06/02/2019
Description:
Opposition procedure started

4

Issue number:
201813
Publication date:
28/03/2018
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
28/02/2026
Annual Fee Number:
19
Annual Fee Amount:
1300 Euro
Last Annual Payment Date:
27/01/2025
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
1200 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
29/06/2018 Outgoing Correspondence Letter no formal defects 1 PDF /1/4/9/2/5/0800252941/docs/ep08729939.2_0_215084l271.pdf
13/06/2018 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /1/4/9/2/5/0800252941/docs/ep08729939.2_1_incomingcorrespondenceelectronic20180613110815464.pdf
13/06/2018 Claims First filed claims 3 PDF /1/4/9/2/5/0800252941/docs/ep08729939.2_2_claims20180613110813986.pdf